Prevention of anticancer | online pharmacy

Olimab 60mg injection DESCRIPTION Olimab 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Olimab 60mg injection PRESCRIBED Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSA

Rozel 60mg injection DESCRIPTION Rozel 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Rozel 60mg injection PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSAGE Fo

Xovoltib 50mg tablet DESCRIPTION Xovoltib 50mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 50mg tablet is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 50mg tablet INDICATION Xovoltib 50mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib 50mg tablet the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impairment: prescribed dose is 30mg taken once per day Take Xovoltib 50mg tablet on an empty stomach. Consume the drug 1 hour befor

Xovoltib 40mg tablets DESCRIPTION Xovoltib 40mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 40mg tablet is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 40mg tablet INDICATION Xovoltib 40mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib 40mg tablet the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is Xovoltib 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impairment: prescribed dose is 30mg taken once per day Take Xovoltib 40mg on an empty stomach. Consume the drug 1 hour befo

Xovoltib 30mg tablets DESCRIPTION Xovoltib 30mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 30mg tablet is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 30mg tablet INDICATION Xovoltib 30mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib 30mg tablet the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impairment: prescribed dose is Xovoltib 30mg taken once per day Take Xovoltib 30mg tablet on an empty stomach. Consume the drug 1 h

Xovoltib 20mg tablets DESCRIPTION Xovoltib 20mg belongs to quinazoline and butanamide derivative which acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER. Xovoltib 20mg tablet is a prescription drugs which is used under the guidance of medical practioners. Xovoltib 20mg tablet INDICATION Xovoltib 20mg is indicated for treatment a certain type of lung cancer (non-small cell lung cancer) which has spread to other parts of the body. DOSAGE Xovoltib 20mg tablet the prescribed dose for the treatment of non-small cell lung cancer as follows : For adult : The prescribed dose is 40mg taken once per day. For child dosage : Ages of 0-17 years is not being studied in children. The drug should not be used age under 18 years of age For renal impairment: prescribed dose is 30mg taken once per day Take Xovoltib 20mg  on an empty stomach. Consume the drug 1 hour before or 2

Xtandi Enzalutamide 40mg capsules Description: Xtandi is a hormonal therapy used for advanced prostate cancer treatment, like for 0men who are all affected with prostate carcinoma in metastatic stage. These are majorly indicated for prostate carcinoma, which contains Enzalutamide, as an active component considered as non steroidal anti-androgen medication. It is involved in association with castration in the therapy of metastatic or long lasting castration resistant prostate cancer. It is a prescribing medicine, the main ingredient which is used as enzalutamide ,only prescribed by medical oncologist.                                                             XTANDI DOSING CONDITIONS AND ADMINISTRATION The usual prescribed dosage of Xtandi is 160mg as a single dose by taking with or without food. Xtandi is available in the strength of 40mg; four Capsules of Xtandi should be administered at a same time. XtandiCapsule should not crush, not chew taken with glass of water. Xtandi

Xgeva 120mg injection Description: Xgeva 120mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides.                                         PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for

Prolia 60mg Injections  Description Prolia 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSAGE For adult : Osteopor